The MED13L Foundation strategic research plan: a roadmap to the future

Heilmann, R., Pfalzer, A., Bichell, T. J., Terala, A., Campbell, A., Taatjes, D., Ghoumid, J., Grueter, C., Bain, J., Strich, R., Dias, V., Sokorai, K., Seaver, N., Sexton, K., & Boychuck, K. (2024). The MED13L Foundation strategic research plan: a roadmap to the future. Therapeutic Advances in Rare Disease, 5. https://doi.org/10.1177/26330040241290252
Authors:
Rachel Heilmann
Anna C. Pfalzer
Terry Jo Bichell
Ananya Terala
Alicia Campbell
Dylan J. Taatjes
Jamal Ghoumid
Chad E. Grueter
Jennifer Bain
Randy Strich
Vanessa C. Dias
Kimberly Sokorai
Nicholas Seaver
Katherine C. Sexton
Kathleen Boychuck
Affiliated Authors:
Jennifer Bain
Columbia Affiliation:
Subjects:
Standards and Guidelines for Genetic Variant Interpretation (OpenAlex Topic)
Molecular Basis of Rett Syndrome and Related Disorders (OpenAlex Topic)
Clustered Regularly Interspaced Short Palindromic Repeats and CRISPR-associated proteins (OpenAlex Topic)
Author Keywords:
med13l
advocacy led research
drug development resources
neurodevelopmental rare disease
patient advocacy organization
research roadmap
elink
Publication Type:
Article
Unique ID:
10.1177/26330040241290252
PMID:
39619418
DOI:
10.1177/26330040241290252
Journal:
Therapeutic Advances in Rare Disease
Publication Date:
Data Source:
OpenAlex
Source Link:
View OpenAlex Record
View PubMed Record

Record Created: